Vertellus Acquires Specialty Ingredients Businesses from Chemtrade

November 3, 2021

Vertellus, a Pritzker Private Capital–backed specialty chemicals manufacturer, completed the acquisition of certain Chemtrade businesses that produce potassium chloride, caustic pellets and vaccine adjuvants. The deal expands Vertellus’ capabilities and product portfolio in the healthcare and pharmaceutical sectors and strengthens its manufacturing footprint for specialty ingredients.

Buyers
Vertellus, Pritzker Private Capital
Targets
Chemtrade Logistics Income Fund
Sellers
Chemtrade Logistics Income Fund
Industry
Manufacturing
Location
Ontario, Canada
Transaction Type
Divestiture

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.